Please log in to view this page
Username
Password
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
